Patient Identification

Target Patient Population (NYHA II-IV)

Previous myocardial infarction (90 days or more) with scar (ischemic)​

Image
Scar
  • Anteroseptal, apical, and/or anterolateral region​
  • Discrete acontractile (akinetic and/or dyskinetic)​
  • Transmural (>50%)​
Dilation
Viable Myocardium

Image Training Manual

Learn how to qualify your patients
Image

BioVentrix® is a privately held medical device company headquartered in Mansfield, MA, USA.

Our News

Contact Us